future glp-1 drugs drugs, even when they fail, are giving researchers new insight about obesity : NPR Market Overview: GLP-1 Agonists and

report appeared

Retatrutide: Phase-2 trial Retatrutide is an investigational triple agonist (GLP-1, GIP and glucagon receptors), adding a third hormone target to potentially boost metabolism further

2016a;375:31122

However, it's essential to consult your healthcare provider before starting any new supplement or dietary change to ensure it is safe and will not interact with your current medications

These drugs are whats known as GLP-1s, just like Ozempic, the popular diabetes medication that kicked off a revolution in the pharmaceutical industry and inspired as many as 12% of people in the U.S

doi: 10.1016/j.pnpbp.2013.04.009 73 HansenH